Imago BioSciences, Inc.
IMGODelisted Jan 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623715
Imago BioSciences, Inc. was delisted on Jan 11, 2023; its insiders filed their last Form 4 on Jan 11, 2023; 106 institutions reported holding it in 13F filings for Q4 2022, worth $1.05B in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Imago BioSciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 65 | 106 | +41 |
| Shares | 31.8M | 29.3M | −2.46M (−7.7%) |
| Value | $478.1M | $1.05B | +$575.7M (+120.4%) |
New holders (56)
Institutions that held Imago BioSciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (15)
Institutions that held Imago BioSciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Farallon Capital Management, L.L.C. | 2,471,313 | $37.2M |
| Price T Rowe Associates Inc | 1,885,112 | $28.4M |
| Emerald Advisers, LLC | 853,637 | $12.8M |
| Emerald Mutual Fund Advisers Trust | 699,960 | $10.5M |
| Matrix Capital Management Company, LP | 361,000 | $5.43M |
| Driehaus Capital Management LLC | 343,846 | $5.17M |
| Parkman Healthcare Partners LLC | 189,193 | $2.85M |
| Ensign Peak Advisors, Inc | 178,567 | $2.69M |
| Monarch Partners Asset Management LLC | 148,915 | $2.24M |
| TD Asset Management Inc | 48,973 | $749.0K |
| Bessemer Group Inc | 12,339 | $186.0K |
| Ameritas Investment Partners, Inc. | 1,556 | $23.0K |
| China Universal Asset Management Co., Ltd. | 316 | $5.00K |
| Wells Fargo & Company | 295 | $4.00K |
| Daiwa Securities Group Inc. | 98 | $1.00K |